The Panic Evidence Map
Prevalence, treatment effect sizes, ED visit patterns, and the long-term remission picture.
Open the map →EVIDENCE MAPS
Evidence Maps.
Visual cluster pages showing how the published evidence on a topic fits together. Each map has a central node and the evidence around it.
Reviewed by Shariq Refai, MD, MBA, FAPA
Evidence rarely lives in one paper. Effect sizes from meta-analyses, signals from registry data, dropout rates from real-world cohorts, and gaps in coverage all matter together. The Evidence Maps lay them out visually so you can see what's solid, what's contested, and what isn't known yet. Each map points back to the source studies and to the rest of the network where the topic shows up in practice.
The maps
The OCD Evidence Map
ERP, SSRI dosing, treatment-resistance pathways, and the comorbidity landscape.
Open the map →The Social Anxiety Evidence Map
CBT effect sizes, exposure for social, group vs individual, beta-blocker considerations.
Open the map →The Exposure Therapy Evidence Map
Inhibitory learning, in vivo vs imaginal, VR exposure, and the dissemination gap.
Open the map →The Medication Evidence Map
SSRIs, SNRIs, benzodiazepines, buspirone, hydroxyzine, pregabalin, and what discontinuation looks like.
Open the map →The maps are built for embedding. Each map has an iframe version at /embed/evidence-maps/<slug>/ with attribution back to AnxietyResearch.org. See the embed widgets page for the snippet.
Your next step in The Shrink Network
You are here: AnxietyResearch, the evidence layer of The Shrink Network.
Each site in the network has one job. No matter where you enter, we help you find the next step that makes sense.
Get clinical care at shrinkMDWant to understand more first?